Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
The Downside Of REMS: An Over-Taxed Health Care System – FDA’s Jenkins
Feb 16 2009
•
By
Lauren Smith
More from Archive
More from Pink Sheet